MEDLINE/PubMed Journal Browser Search

Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

Title: Oral contraceptives increase insulin-like growth factor binding protein-1 concentration in women with polycystic ovarian disease.
Author: Suikkari AM, Tiitinen A, Stenman UH, Seppälä M, Laatikainen T.
Journal: Fertil Steril; 1991 May; 55(5):895-9. PubMed ID: 1708731.
Abstract:
UNLABELLED: Insulin-like growth factor-I (IGF-I) stimulates ovarian androgen production. Insulin-like growth factor binding protein-1 (IGFBP-1) inhibits IGF actions in vitro. OBJECTIVE: To investigate the effect of oral contraceptive (OC) pills, given for 3 months, on serum gonadotropin, androgen, IGF-I, and IGFBP-1 concentrations, and glucose tolerance in seven women with polycystic ovarian disease (PCOD) and in five healthy control subjects. PATIENTS: Seven women with PCOD and five healthy control subjects. INTERVENTIONS: An oral glucose tolerance test (OGTT) was performed before and after treatment with OC. RESULTS: After treatment with OC, serum luteinizing hormone, androstenedione, and free testosterone levels decreased, and sex hormone-binding globulin concentration increased in the women with PCOD as well as in the control subjects. The cumulative response of serum insulin to OGTT was larger in the women with PCOD than in the control subjects both before and after treatment. Serum IGF-I concentration, which was unchanged during OGTT, decreased from basal level of 326 +/- 70 micrograms/L to 199 +/- 28 micrograms/L after treatment with OC in the women with PCOD, whereas no change was found in the control subjects (from 235 +/- 11 micrograms/L to 226 +/- 11 micrograms/L). Treatment with OC caused an increase of the mean basal IGFBP-1 concentration from 24 +/- 7 micrograms/L to 73 +/- 14 micrograms/L in the women with PCOD. This increase was constant during the OGTT. In the control subjects, treatment with OC did not result in any significant change in IGFBP-1 concentrations (from 44 +/- 11 micrograms/L to 61 +/- 9 micrograms/L). CONCLUSION: The combination of decreased total IGF-I concentration and increased IGFBP-1 concentration induced by OC may decrease ovarian androgen production in PCOD. Insulin-like growth factor-I (IGF-I) stimulates ovarian androgen production. Insulin-like growth factor binding protein-1 (IGFBP-1) inhibits IGF actions in vitro. The objective of this study was to investigate the effect of oral contraceptives (OCs), administered for 3 months, on serum gonadotropin, androgen, IGF-I, and IGFBP-1 concentrations, and glucose tolerance in 7 women with polycystic ovarian disease (PCOD) and in 5 healthy subjects. An oral glucose tolerance test (OGTT) was performed before and after treatment with OCs. After treatment, serum luteinizing hormone, androstenedione, and free testosterone levels decreased, and sex hormone-binding globulin concentrations increased in the women with PCOD as well as in the controls. The cumulative response of serum insulin to OGTT was larger in women with PCOD than in the controls, both before and after treatment. Serum IGF-I concentration, which was unchanged during OGTT, decreased from a basal level of 326 +or- 70 mcg/L to 199 +or- 28 mcg/L after OC treatment in those women with PCOD, whereas no change was found in the controls (from 235 +or- 11 mcg/L to 22 +or- 11 mcg/L). Treatment with OCs caused an increase in the mean basal IGFBP-1 concentrations from 24 +or- 7 mcg/L to 73 +or- 14 mcg/L in the women with PCOD. This increase was constant during OGTT. Among the control subjects, treatment with OCs did not result in any significant change in IGFBP-1 concentrations (from 44 +or- mcg/L to 61 +or- 9 mcg/L). The combination of decreased total IGF-1 concentration and increased IGFBP-1 concentration induced by OCs may decrease ovarian androgen production in PCOD.

[Abstract] [Full Text] [Related] [New Search]